Structure-based design of human immuno- and constitutive proteasomes inhibitors - Université de Rennes Access content directly
Journal Articles European Journal of Medicinal Chemistry Year : 2018

Structure-based design of human immuno- and constitutive proteasomes inhibitors

Abstract

Starting from the X-ray structure of our previous tripeptidic linear mimics of TMC-95A in complex with yeast 20S proteasome, we introduced new structural features to induce a differential inhibition between human constitutive and immunoproteasome 20S particles. Libraries of 24 tripeptidic and 6 dipeptidic derivatives were synthesized. The optimized preparation of 3-hydroxyoxindolyl alanine residues from tryptophan and their incorporation in peptides were described. Several potent inhibitors of human constitutive proteasome and immunoproteasome acting at the nanomolar level (IC50 = 7.1 nM against the chymotrypsin-like activity for the best inhibitor) were obtained. A cytotoxic effect at the submicromolar level was observed against 6 human cancer cell lines.
Fichier principal
Vignette du fichier
Richy et al_Structure-based design of human immuno- and constitutive proteasomes inhibitors.pdf (680.89 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01713510 , version 1 (25-04-2018)

Identifiers

Cite

N. Richy, D. Sarraf, X. Maréchal, N. Janmamode, E. Genin, et al.. Structure-based design of human immuno- and constitutive proteasomes inhibitors. European Journal of Medicinal Chemistry, 2018, 145, pp.570-587. ⟨10.1016/j.ejmech.2018.01.013⟩. ⟨hal-01713510⟩
285 View
283 Download

Altmetric

Share

Gmail Facebook X LinkedIn More